Soleus Capital Management as of Dec. 31, 2021
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 68 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr Ser Tr S&p Biotech Put Option (XBI) | 14.5 | $145M | 1.3M | 111.96 | |
Ishares Tr Russell 2000 Etf Put Option (IWM) | 11.3 | $113M | 509k | 222.45 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 5.1 | $51M | 1.8M | 28.89 | |
Essa Pharma Com New (EPIX) | 5.0 | $50M | 3.5M | 14.20 | |
Bioatla (BCAB) | 4.9 | $49M | 2.5M | 19.63 | |
United Therapeutics Corporation (UTHR) | 3.6 | $36M | 164k | 216.08 | |
Astrazeneca Sponsored Adr (AZN) | 2.8 | $28M | 479k | 58.25 | |
SurModics (SRDX) | 2.6 | $26M | 533k | 48.15 | |
Enanta Pharmaceuticals (ENTA) | 2.4 | $24M | 318k | 74.78 | |
Theratechnologies | 2.3 | $23M | 7.7M | 3.03 | |
Neuropace (NPCE) | 2.3 | $23M | 2.3M | 10.08 | |
Fibrogen (FGEN) | 2.2 | $22M | 1.6M | 14.10 | |
Nurix Therapeutics (NRIX) | 2.2 | $22M | 743k | 28.95 | |
Natera (NTRA) | 2.1 | $21M | 228k | 93.39 | |
Iradimed (IRMD) | 2.1 | $21M | 450k | 46.21 | |
Smith & Nephew Spdn Adr New (SNN) | 2.1 | $21M | 593k | 34.62 | |
Dice Therapeutics | 2.1 | $21M | 811k | 25.31 | |
Apollo Endosurgery | 1.9 | $19M | 2.3M | 8.43 | |
Edap Tms S A Sponsored Adr (EDAP) | 1.9 | $19M | 3.1M | 5.99 | |
Organogenesis Hldgs (ORGO) | 1.8 | $19M | 2.0M | 9.24 | |
C4 Therapeutics Com Stk (CCCC) | 1.8 | $18M | 561k | 32.20 | |
Iveric Bio | 1.8 | $18M | 1.1M | 16.72 | |
Krystal Biotech (KRYS) | 1.6 | $16M | 228k | 69.95 | |
CVS Caremark Corporation (CVS) | 1.4 | $14M | 138k | 103.16 | |
AngioDynamics (ANGO) | 1.4 | $14M | 516k | 27.58 | |
Steris Shs Usd (STE) | 1.3 | $13M | 52k | 243.42 | |
Xenon Pharmaceuticals (XENE) | 1.2 | $12M | 379k | 31.24 | |
CVRX (CVRX) | 1.2 | $12M | 962k | 12.23 | |
Evolus (EOLS) | 0.8 | $8.2M | 1.3M | 6.51 | |
Xilio Therapeutics (XLO) | 0.8 | $7.6M | 478k | 16.00 | |
Vaxcyte (PCVX) | 0.7 | $7.0M | 295k | 23.79 | |
Sientra | 0.7 | $6.9M | 1.9M | 3.67 | |
Inspire Med Sys (INSP) | 0.6 | $6.3M | 28k | 230.05 | |
Bioventus Com Cl A (BVS) | 0.6 | $6.2M | 428k | 14.49 | |
Pacira Pharmaceuticals (PCRX) | 0.6 | $6.1M | 102k | 60.17 | |
Galapagos Nv Spon Adr (GLPG) | 0.5 | $5.4M | 99k | 55.13 | |
Cara Therapeutics (CARA) | 0.5 | $5.2M | 427k | 12.18 | |
Y Mabs Therapeutics (YMAB) | 0.5 | $5.0M | 311k | 16.21 | |
Chinook Therapeutics | 0.5 | $4.9M | 299k | 16.31 | |
Baxter International (BAX) | 0.4 | $4.4M | 51k | 85.84 | |
Io Biotech (IOBT) | 0.4 | $4.3M | 673k | 6.40 | |
Dex (DXCM) | 0.4 | $4.2M | 7.8k | 536.92 | |
Dyne Therapeutics (DYN) | 0.4 | $4.0M | 339k | 11.89 | |
Abbvie (ABBV) | 0.4 | $3.7M | 28k | 135.42 | |
Arena Pharmaceuticals Com New | 0.4 | $3.7M | 40k | 92.95 | |
Cutera (CUTR) | 0.4 | $3.6M | 86k | 41.32 | |
Da32 Life Scnce Tec Acqstn C Class A Com | 0.3 | $3.4M | 350k | 9.81 | |
Verastem | 0.3 | $3.4M | 1.6M | 2.05 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.3 | $3.0M | 300k | 9.92 | |
Zogenix Com New | 0.3 | $2.8M | 175k | 16.25 | |
Pieris Pharmaceuticals (PIRS) | 0.3 | $2.6M | 687k | 3.78 | |
Vanda Pharmaceuticals (VNDA) | 0.2 | $2.5M | 159k | 15.69 | |
Chemocentryx | 0.2 | $2.5M | 68k | 36.42 | |
Miragen Therapeutics (VRDN) | 0.2 | $1.8M | 90k | 19.77 | |
Immunic (IMUX) | 0.2 | $1.7M | 175k | 9.57 | |
Novocure Ord Shs (NVCR) | 0.2 | $1.7M | 22k | 75.06 | |
Crispr Therapeutics Namen Akt (CRSP) | 0.2 | $1.7M | 22k | 75.77 | |
Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.1 | $1.4M | 2.0M | 0.74 | |
Avalo Therapeutics | 0.1 | $1.3M | 770k | 1.70 | |
Liquidia Corporation Com New (LQDA) | 0.1 | $1.1M | 232k | 4.87 | |
Arvinas Ord (ARVN) | 0.1 | $904k | 11k | 82.18 | |
Werewolf Therapeutics (HOWL) | 0.1 | $769k | 65k | 11.91 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.1 | $624k | 10k | 60.88 | |
Fate Therapeutics (FATE) | 0.0 | $456k | 7.8k | 58.46 | |
Celcuity (CELC) | 0.0 | $423k | 32k | 13.19 | |
Ngm Biopharmaceuticals (NGM) | 0.0 | $230k | 13k | 17.69 | |
Beam Therapeutics (BEAM) | 0.0 | $227k | 2.9k | 79.65 | |
Lyra Therapeutics (LYRA) | 0.0 | $44k | 10k | 4.40 |